Laurus Labs Ltd - 540222 - Board Meeting Outcome for Outcome Of Board Meeting Held On January 30, 2023
Outcome of Board Meeting held on January 30, 202330-01-2023
30-01-2023
Laurus Labs Ltd - 540222 - Un-Audited Financial Results For Q3 FY 23
Un-Audited Financial Results for Q3 FY 2330-01-2023
Laurus Labs Ltd - 540222 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
LAURUS LABS LTD. Q3 & 9M FY23 RESULTS CONFERENCE CALL ON MONDAY, 30TH JANUARY 2023 AT 5.00 P.M. (IST)21-01-2023
Laurus Labs Ltd - 540222 - Board Meeting Intimation for Approval Of Un-Audited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2022
Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2023 ,inter alia, to consider and approve Un-Audited Financial Results of the Company for the quarter and nine months ended December 31, 202221-01-2023
Laurus Labs Ltd - 540222 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Further to our intimation dated October 28, 2022, on the Pre-Approval Inspection (PAI) conducted by the United States Food & Drug Administration (USFDA) at our manufacturing facility at Unit-5, Parawada, Visakhapatnam, Andhra Pradesh from 24th October 2022 to 28th October 2022, we wish to inform you that the Company has received the Establishment Inspection Report (EIR) from USFDA. This is for your information and record.20-01-2023
Mehul Kothari recommends to buy Laurus Labs, RateGain Travel Technologies
According to the technical analyst from Anand Rathi, Laurus Labs can rally to Rs 400; while RateGain can jump to Rs 330.10-01-2023
Laurus Labs Ltd - 540222 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In accordance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 and based on the certificates received from KFin Technologies Limited (Formerly known as KFin Technologies Private Limited) [Registrar and Share Transfer Agent], we hereby confirm that no requests received from depository participants for dematerialization of securities during the quarter ended December 31, 2022. This is for your information and records.07-01-2023
Laurus Labs Ltd - 540222 - Closure of Trading Window
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the shares of the Company shall remain closed from January 01, 2023 till 48 hours after the declaration of un-audited financial results for the quarter and nine months ended December 31, 2022. The date of Board Meeting of the Company for consideration and approval of the un-audited financial results for the quarter and nine months ended December 31, 2022 will be intimated later.31-12-2022
4 dead, 1 injured at Laurus Labs' Vizag unit fire
The fire occurred in a manufacturing block of API plant27-12-2022
Laurus Labs Ltd - 540222 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
We regret to inform you that on the evening of 26th December 2022 flash fire occurred in one of the rooms in one manufacturing block of our API manufacturing plant (Unit 3), Jawaharlal Nehru Pharma City, Parawada, Anakapally district, Visakhapatnam, Andhra Pradesh. The operations in the other production blocks are running normally. Further, we deeply regret to inform that two of regular employees and two contract employees have lost their lives after reaching hospital. One regular employee is in hospital and undergoing treatment. We extend our full support to the families. The Company launched investigation into the incident. The Company estimates that no material impact on the operations. This is for your information and record.27-12-2022